These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

914 related articles for article (PubMed ID: 19262490)

  • 1. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
    Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S;
    Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should central obesity be an optional or essential component of the metabolic syndrome? Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study.
    Lee J; Ma S; Heng D; Tan CE; Chew SK; Hughes K; Tai ES
    Diabetes Care; 2007 Feb; 30(2):343-7. PubMed ID: 17259505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan.
    Inoue M; Noda M; Kurahashi N; Iwasaki M; Sasazuki S; Iso H; Tsugane S;
    Eur J Cancer Prev; 2009 Jun; 18(3):240-7. PubMed ID: 19491612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO.
    Ma WY; Li HY; Hung CS; Lin MS; Chiu FC; Lin CH; Shih SR; Chuang LM; Wei JN
    Diabetes Res Clin Pract; 2009 Sep; 85(3):335-41. PubMed ID: 19608293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Rasmussen S; Ibsen H; Torp-Pedersen C; Madsbad S
    J Am Coll Cardiol; 2007 May; 49(21):2112-9. PubMed ID: 17531661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
    Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
    BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
    DECODE Study Group
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of central obesity as a prerequisite for the diagnosis of metabolic syndrome.
    Khoo CM; Liew CF; Chew SK; Tai ES
    Obesity (Silver Spring); 2007 Jan; 15(1):262-9. PubMed ID: 17228055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects.
    Milionis HJ; Kostapanos MS; Liberopoulos EN; Goudevenos J; Athyros VG; Mikhailidis DP; Elisaf MS
    Int J Clin Pract; 2007 Apr; 61(4):545-51. PubMed ID: 17394429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey.
    ; Bonadonna R; Cucinotta D; Fedele D; Riccardi G; Tiengo A
    Diabetes Care; 2006 Dec; 29(12):2701-7. PubMed ID: 17130208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.
    Arnlöv J; Ingelsson E; Sundström J; Lind L
    Circulation; 2010 Jan; 121(2):230-6. PubMed ID: 20038741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
    Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
    Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMI versus the metabolic syndrome in relation to cardiovascular risk in elderly Chinese individuals.
    He Y; Jiang B; Wang J; Feng K; Chang Q; Zhu S; Fan L; Li X; Hu FB
    Diabetes Care; 2007 Aug; 30(8):2128-34. PubMed ID: 17468350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.